Trulicity and Keppra drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Trulicity (dulaglutide) and Keppra (levetiracetam). Common drug interactions include alopecia among females and atrial fibrillation among males.
The phase IV clinical study analyzes what interactions people have when they take Trulicity and Keppra. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.
What is Trulicity?
Trulicity has active ingredients of dulaglutide. It is often used in weight loss. eHealthMe is studying from 77,529 Trulicity users. Check the latest studies of Trulicity.
What is Keppra?
Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.
54 people who take Trulicity and Keppra together, and have interactions are studied.

What are the common drug interactions of Trulicity and Keppra, by gender? *:
female:
- Alopecia (absence of hair from areas of the body)
- Blood glucose decreased
- Fall
- Fatigue (feeling of tiredness)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Hidradenitis (chronic disease of a type of sweat gland)
- Impaired gastric emptying
- Influenza
- Injection site bruising
- Injection site pain
male:
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Acute respiratory failure
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hypertension (high blood pressure)
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Loss of consciousness
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
- Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
What are the common drug interactions of Trulicity and Keppra, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Pulmonary haemorrhage (acute bleeding from the lung)
- Death
- Pneumonia
- Streptococcal infection
30-39:
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Blood glucose decreased
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
- Injection site bruising
- Injection site pain
- Pruritus (severe itching of the skin)
40-49:
- Disturbance in attention
- Hypercalcaemia (elevated calcium (ca+) level in the blood)
- Hypernatraemia (an abnormally high plasma concentration of sodium ions)
- Hypotension (abnormally low blood pressure)
- Pneumonia
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Urinary tract infection enterococcal
- Anxiety
- Depression
- Fatigue (feeling of tiredness)
50-59:
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Fall
- Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
- Nausea (feeling of having an urge to vomit)
- Acute respiratory failure
- Asthenia (weakness)
- Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
- Chills (felling of cold)
- Constipation
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
60+:
- Acute respiratory failure
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Cataract (clouding of the lens inside the eye)
- Cerebral haemorrhage (bleeding within the brain)
- Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
- Chest pain
- Diabetes mellitus inadequate control
- Diarrhoea
- Drug eruption (adverse drug reaction of the skin)
- Fatigue (feeling of tiredness)
What are the existing conditions these people have? *
- Type 2 Diabetes: 9 people, 16.67%
- Diabetes: 9 people, 16.67%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 8 people, 14.81%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 14.81%
- Constipation: 5 people, 9.26%
- Immunodeficiency Common Variable: 4 people, 7.41%
- Depression: 4 people, 7.41%
- Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 3 people, 5.56%
- Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 5.56%
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 3 people, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Trulicity and Keppra?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Trulicity and Keppra:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Trulicity:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Keppra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Trulicity and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Keppra and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on dulaglutide and levetiracetam (the active ingredients of Trulicity and Keppra, respectively), and Trulicity and Keppra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Allegra cause Multi-Organ Disorder? - a second ago
- Could Allegra cause Infusion Site Irritation? - 3 seconds ago
- Could Zide cause Auricular Swelling? - 5 seconds ago
- Could Zide cause Acute Myeloid Leukaemia Aggravated? - 8 seconds ago
- Telmisartan; Hydrochlorothiazide vs. Cardizem Cd, side effect and effectiveness comparison - 22 seconds ago
- Avinza vs. Tramadol And Acetaminophen, side effect and effectiveness comparison - 24 seconds ago
- Could Penicillin cause Appetite Decreased? - 28 seconds ago
- Could Penicillin cause Appetite - Decreased? - 28 seconds ago
- Could Paclitaxel cause Cerebral Haemorrhage? - 31 seconds ago
- Could Carvedilol cause Hypertransaminasaemia? - 49 seconds ago